SEC Tracker
Get the app

Alpine Immune Sciences

OrbiMed Private Investments VI (Shareholder) plans to sell 1,385,131 shares, about $28M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Dec 27, 2023
  2. Broker: Themis Trading LLC
  3. Shares acquired by: Business combination

All of OrbiMed Private Investments VI's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 18,922 shares at $19.96 on Dec 27, 2023 · Form 4
  • Sold 26,872 shares at $19.82 on Dec 28, 2023 · Form 4
  • Sold 3,128 shares at $19.82 on Dec 28, 2023 · Form 4
  • Sold 1,195,683 shares at $18.32 on Dec 28, 2023 · Form 4
  • Sold 139,166 shares at $18.32 on Dec 28, 2023 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Alpine Immune Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX

Data on this page was fetched . The filing on SEC.gov is the record.